Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Lenvatinib + Pembrolizumab for Kidney Cancer
Recruiting1 awardPhase 2
New Orleans, Louisiana
This trial is testing a new combination therapy for people with kidney cancer that has spread and is not able to be removed by surgery.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.